Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration

NCT01176903 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Glycopyrrolate
DRUG: Tiotropium
DRUG: placebo

Sponsor

Chiesi Farmaceutici S.p.A.